31 – 40 of 45
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Beta-blocker therapy after myocardial infarction guided by left ventricular ejection fraction : Is 50 the new 40?
- Contribution to journal › Debate/Note/Editorial
- 2020
-
Mark
Diagnostic accuracy of troponin T measured ≥6h after symptom onset for ruling out myocardial infarction
- Contribution to journal › Article
-
Mark
Temporal trends in bleeding events in acutemyocardial infarction : Insights from the SWEDEHEARTregistry
- Contribution to journal › Article
-
Mark
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic
- Contribution to journal › Article
- 2019
-
Mark
Elevated IL-27 in patients with acute coronary syndrome is associated with adverse ventricular remodeling and increased risk of recurrent myocardial infarction and cardiovascular death
- Contribution to journal › Article
-
Mark
Inhibition of pro-inflammatory myeloid cell responses by short-term S100A9 blockade improves cardiac function after myocardial infarction
- Contribution to journal › Article
-
Mark
The soluble receptor for advanced glycation end-products (sRAGE) has a dual phase-dependent association with residual cardiovascular risk after an acute coronary event.
- Contribution to journal › Article
- 2018
-
Mark
Registry-based randomised clinical trial : Efficient evaluation of generic pharmacotherapies in the contemporary era
- Contribution to journal › Article
-
Mark
Long-Term Effects of Oxygen Therapy on Death or Hospitalization for Heart Failure in Patients With Suspected Acute Myocardial Infarction
- Contribution to journal › Article
-
Mark
Relations between implementation of new treatments and improved outcomes in patients with non-ST-elevation myocardial infarction during the last 20 years : experiences from SWEDEHEART registry 1995 to 2014
- Contribution to journal › Article
